ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 230 filers reported holding ICU MED INC in Q1 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $28,096,357 | -33.4% | 236,084 | -0.2% | 0.01% | -37.5% |
| Q2 2023 | $42,163,852 | +1.3% | 236,623 | -6.2% | 0.01% | 0.0% |
| Q1 2023 | $41,610,831 | +8.2% | 252,248 | +3.3% | 0.01% | 0.0% |
| Q4 2022 | $38,448,428 | -0.2% | 244,148 | -4.6% | 0.01% | -11.1% |
| Q3 2022 | $38,532,000 | -2.4% | 255,858 | +6.5% | 0.01% | +12.5% |
| Q2 2022 | $39,491,000 | -21.9% | 240,230 | +5.7% | 0.01% | -11.1% |
| Q1 2022 | $50,597,000 | -9.2% | 227,256 | -3.2% | 0.01% | 0.0% |
| Q4 2021 | $55,733,000 | +1.9% | 234,825 | +0.2% | 0.01% | -10.0% |
| Q3 2021 | $54,683,000 | +16.9% | 234,314 | +3.1% | 0.01% | +25.0% |
| Q2 2021 | $46,784,000 | +4.0% | 227,329 | +3.8% | 0.01% | 0.0% |
| Q1 2021 | $44,987,000 | +4.7% | 218,969 | +9.3% | 0.01% | 0.0% |
| Q4 2020 | $42,961,000 | +18.3% | 200,294 | +0.8% | 0.01% | 0.0% |
| Q3 2020 | $36,308,000 | -2.9% | 198,666 | -2.1% | 0.01% | -11.1% |
| Q2 2020 | $37,393,000 | -6.2% | 202,879 | +2.7% | 0.01% | -18.2% |
| Q1 2020 | $39,853,000 | +11.9% | 197,515 | +3.8% | 0.01% | +37.5% |
| Q4 2019 | $35,605,000 | +17.9% | 190,280 | +0.5% | 0.01% | +14.3% |
| Q3 2019 | $30,204,000 | -29.2% | 189,245 | +11.8% | 0.01% | -30.0% |
| Q2 2019 | $42,645,000 | +8.6% | 169,287 | +3.2% | 0.01% | 0.0% |
| Q1 2019 | $39,266,000 | +14.0% | 164,067 | +9.4% | 0.01% | 0.0% |
| Q4 2018 | $34,437,000 | -15.7% | 149,970 | +3.8% | 0.01% | 0.0% |
| Q3 2018 | $40,856,000 | -5.4% | 144,493 | -1.8% | 0.01% | -9.1% |
| Q2 2018 | $43,210,000 | -30.7% | 147,147 | -40.4% | 0.01% | -31.2% |
| Q1 2018 | $62,337,000 | +41.8% | 246,976 | +21.3% | 0.02% | +45.5% |
| Q4 2017 | $43,971,000 | +14.1% | 203,566 | -1.8% | 0.01% | +10.0% |
| Q3 2017 | $38,537,000 | +5.6% | 207,357 | -2.0% | 0.01% | 0.0% |
| Q2 2017 | $36,507,000 | +19.9% | 211,637 | +6.1% | 0.01% | +11.1% |
| Q1 2017 | $30,457,000 | +4.7% | 199,455 | +1.0% | 0.01% | 0.0% |
| Q4 2016 | $29,090,000 | +29.1% | 197,414 | +10.7% | 0.01% | +28.6% |
| Q3 2016 | $22,532,000 | +13.0% | 178,288 | +0.8% | 0.01% | +16.7% |
| Q2 2016 | $19,934,000 | +12.7% | 176,798 | +4.1% | 0.01% | 0.0% |
| Q1 2016 | $17,685,000 | -6.4% | 169,768 | +1.3% | 0.01% | 0.0% |
| Q4 2015 | $18,892,000 | +4.3% | 167,520 | +1.3% | 0.01% | 0.0% |
| Q3 2015 | $18,115,000 | +28.1% | 165,432 | +11.9% | 0.01% | +50.0% |
| Q2 2015 | $14,139,000 | -1.7% | 147,798 | -4.3% | 0.00% | 0.0% |
| Q1 2015 | $14,384,000 | +13.3% | 154,421 | -0.4% | 0.00% | 0.0% |
| Q4 2014 | $12,695,000 | +24.8% | 155,013 | -2.2% | 0.00% | +33.3% |
| Q3 2014 | $10,171,000 | +0.9% | 158,481 | -4.4% | 0.00% | 0.0% |
| Q2 2014 | $10,079,000 | -7.5% | 165,734 | -8.9% | 0.00% | 0.0% |
| Q1 2014 | $10,892,000 | -12.4% | 181,888 | -6.8% | 0.00% | -25.0% |
| Q4 2013 | $12,436,000 | -5.3% | 195,189 | +0.9% | 0.00% | -20.0% |
| Q3 2013 | $13,135,000 | -5.3% | 193,373 | +0.4% | 0.01% | 0.0% |
| Q2 2013 | $13,877,000 | – | 192,569 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |